Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple checklist boost heart surgery recovery?

NCT ID NCT07783204

Knowledge-focused Sponsor: Bursa City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Sep 09, 2026 · Updated 2 times

Summary

This study is looking at whether following an Enhanced Recovery After Surgery (ERAS) protocol—a set of steps before, during, and after surgery—is linked to better nutrition and recovery in adults having open heart surgery. Researchers will track how closely patients follow the protocol and measure changes in nutritional risk and frailty. They will also record complications, hospital stay length, and readmissions. The goal is to see if higher ERAS compliance is associated with better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ERAS protocol compliance assessment (no therapeutic intervention)
What this could lead to
If a clear link is found, it could support wider use of ERAS protocols to improve recovery and reduce complications after heart surgery.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by other factors, and the findings may not apply to all heart surgery patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of consecutive adult patients aged 18 to 85 years who are scheduled to undergo elective open heart surgery through median sternotomy at Bursa City Hospital. Eligible participants will receive routine perioperative care according to the institutional cardiac surgery ERAS protocol. Participants will be observed prospectively and categorized according to their overall ERAS compliance rate as high (≥80%), moderate (60-79%), or low (\<60%) compliance.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 to 85 years * Scheduled to undergo elective open heart surgery through median sternotomy under general anesthesia * Able to provide written informed consent Exclusion Criteria: * Emergency cardiac surgery * Preoperative total parenteral nutrition * End-stage renal disease or severe hepatic failure * Uncontrolled metabolic disease, including uncontrolled diabetes mellitus or hypertension * Active infection * Cognitive or mental impairment preventing valid informed consent * Pregnancy, suspected pregnancy, or breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac surgery Frailty Nutritional risk

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bursa City Hospital

    RECRUITING

    Bursa, Nilüfer, 16110, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.